Imatinib vs Sars-Cov-2 Virus Spike Protein
Imatinib vs Sars-Cov-2 Virus Spike Protein: Overview
This comparison examines the pharmacological differences between Imatinib and Sars-Cov-2 Virus Spike Protein.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Pharmacokinetics
Half-life: Imatinib — 18 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O.
Molecular Weight: Imatinib — 493.6030 g/mol.
Type: Imatinib — Small molecule; Sars-Cov-2 Virus Spike Protein — Vaccine component.